[
    "{\"step_by_step_thinking\": \"The documents mention several small molecule CGRP antagonists that are under development for the treatment of migraine. For example, Document [2] mentions ubrogepant and rimegepant, which are in clinical development. Document [3] also mentions rimegepant and ubrogepant as effective for the acute treatment of migraine. Document [4] talks about the gepant class of CGRP receptor antagonists. Document [5] mentions ubrogepant, rimegepant, and atogepant as orally administered next-generation small molecule CGRP-RAs. Therefore, the answer is yes, there are small molecule CGRPs under development for the treatment of migraine.\", \"answer_choice\": \"A\"}"
]